Psychiatric comorbidity in methamphetamine dependence
Open accessAbstract
The primary aim of the present study was to assess the prevalence of psychiatric comorbidity in a large sample of methamphetamine (MA)-dependent subjects using a validated structured clinical interview, without limitation to sexual orientation or participation in a treatment program. The secondary aim was to assess whether the prevalence of psychiatric comorbidities varied by gender. Structured clinical interviews (SCIDs) were administered to 189 MA-dependent subjects and lifetime prevalence of DSM-IV diagnoses was assessed. Across the sample, 28.6% had primary psychotic disorders, 23.8% of which were substance-induced; 13.2% had MA-induced delusional disorders and 11.1% had MA-induced hallucinations. A substantial number of lifetime mood disorders were identified that were not substance-induced (32.3%), whereas 14.8% had mood disorders induced by substances, and 10.6% had mood disorders induced by amphetamines. Of all participants, 26.5% had anxiety disorders and 3.7% had a substance-induced anxiety disorder, all of which were induced by MA. Male subjects reported a higher percentage of MA-induced delusions compared to female abusers. Given the impact of MA psychosis and other drug-induced symptoms on hospitals and mental health services, the description and characterization of comorbid psychiatric symptoms associated with MA use is of paramount importance.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Methamphetamine use is highly comorbid with anxiety disorders and psychological interventions are currently the front-line treatment for stimulants, yet studies investigating the effectiveness of psychological interventions among patients with comorbid anxiety disorders remain under researched.
“Methamphetamine use is highly comorbid with anxiety disorders and psychological interventions are currently the front-line treatment for stimulants, yet studies investigating the effectiveness of psychological interventions among patients with comorbid anxiety disorders remain under researched.(Salo et al., 2011; Stuart et al., 2020)”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Salo et al., 2011
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · see citing works
Structured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 3,582 · see citing works
Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0211 · Cited by 934 · cited 4× · see citing works
“The NESARC (Conway et al., 2006) described earlier reported a lifetime prevalence for anxiety disorders of 50% among amphetamine users, but the percentage of substance-induced anxiety disorders was not reported.”
InfluentialPrevalence and Correlates of Drug Use and Dependence in the United States
Warner, L. A. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950150051010 · Cited by 511 · see citing works
Stinson, F. S., Grant, B. F., Dawson, D. A., Ruan, W. J., Huang, B., & Saha, T. D. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.03.009 · Cited by 505 · see citing works
Psychiatric Symptoms in Methamphetamine Users
Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., Iguchi, M. Y., & Methamphetamine Treatment Project (2004) · American Journal on Addictions · doi:10.1080/10550490490436055 · Cited by 469 · see citing works
Self-citationMethamphetamine use behaviors and gender differences
Brecht, M., O’Brien, A., von Mayrhauser, C., & Anglin, M. D. (2003) · Addictive Behaviors · doi:10.1016/s0306-4603(03)00082-0 · Cited by 444 · see citing works
The prevalence of psychotic symptoms among methamphetamine users
McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. M. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01496.x · Cited by 393 · see citing works
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
CHEN, C.-K., LIN, S.-K., SHAM, P. C., BALL, D., LOH, E.-W., HSIAO, C.-C., CHIANG, Y.-L., REE, S.-C., LEE, C.-H., & MURRAY, R. M. (2003) · Psychological Medicine · doi:10.1017/s0033291703008353 · Cited by 295 · see citing works
Ouimette, P. C., Moos, R. H., & Finney, J. W. (1998) · Journal of Studies on Alcohol · doi:10.15288/jsa.1998.59.513 · Cited by 249 · see citing works
Principles of addiction medicine
Ries, R. R., Fiellin, D. A., Miller, S. C., & Saitz, R. (2009) · Cited by 218 · see citing works
Methamphetamine use among young adults: Health and social consequences
Sommers, I. B., Baskin, D. R., & Baskin–Sommers, A. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.10.004 · Cited by 199 · see citing works
SHOPTAW, S. J., Peck, J. A., Reback, C. J., & Rotheram-Fuller, E. J. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400511 · Cited by 147 · see citing works
Psychological morbidity and route of administration among amphetamine users in Sydney, Australia
Hall, W., Hando, J., Darke, S. G., & Ross, J. E. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.9118110.x · Cited by 146 · see citing works
Depression Among Methamphetamine Users
Glasner, S. V., Marinelli‐Casey, P., Hillhouse, M. P., Ang, A., Mooney, L. J., & Rawson, R. A. (2009) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e31819db6fe · Cited by 142 · see citing works
Psychopathology in methamphetamine-dependent adults 3 years after treatment
GLASNER‐EDWARDS, S., MOONEY, L. J., MARINELLI‐CASEY, P., HILLHOUSE, M., ANG, A., RAWSON, R. A., & THE METHAMPHETAMINE TREATMENT PROJECT CORPORATE AUTHORS (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00081.x · Cited by 128 · see citing works
Psychiatric Comorbidity of Methamphetamine Dependence in a Forensic Sample
Kalechstein, A. D., Newton, T. F., Longshore, D. L., Anglin, M. D., van Gorp, W. G., & Gawin, F. H. (2000) · Journal of Neuropsychiatry · doi:10.1176/jnp.12.4.480 · Cited by 124 · see citing works
Mahoney, J. J., Kalechstein, A. D., Garza, R. D. L., & Newton, T. F. (2008) · American Journal on Addictions · doi:10.1080/10550490701861201 · Cited by 107 · see citing works
Gray, S. D., Fatovich, D. M., McCoubrie, D. L., & Daly, F. F. S. (2007) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb00932.x · Cited by 105 · see citing works
United Nations Office on Drugs and Crime (2009) · World drug report · doi:10.18356/1d3bc170-en · Cited by 86 · see citing works
Lin, S., Ball, D., Hsiao, C., Chiang, Y.-L., Ree, S., & CHEN, C. (2004) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2003.01218.x · Cited by 84 · see citing works
Association between Psychiatric Symptoms and Craving in Methamphetamine Users
Nakama, H., Chang, L., Cloak, C. C., Jiang, C. S., Alicata, D., & Haning, W. (2008) · American Journal on Addictions · doi:10.1080/10550490802268462 · Cited by 76 · see citing works
Clinical course and outcomes of methamphetamine-dependent adults with psychosis
Glasner, S. V., Mooney, L. J., Marinelli‐Casey, P., Hillhouse, M. P., Ang, A., & Rawson, R. A. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.12.004 · Cited by 76 · see citing works
Psychological morbidity and route of administration among amphetamine users in Sydney, Australia
Hall, W., Hando, J., Darke, S. G., et al. (1996) · Addiction · doi:10.1111/j.1360-0443.1996.tb03163.x · Cited by 74 · see citing works
Risk Factors for Suicide Attempts in Methamphetamine‐Dependent Patients
Glasner, S. V., Mooney, L. J., Marinelli‐Casey, P., Hillhouse, M. P., Ang, A., Rawson, R. A., & the Methamphetamine Treatment Project Corporate Authors (2008) · American Journal on Addictions · doi:10.1080/10550490701756070 · Cited by 63 · see citing works
Ziedonis, D. M., Rayford, B. S., BRYANT, K. J., & Rounsaville, B. J. (1994) · Psychiatric Services · doi:10.1176/ps.45.1.43 · Cited by 63 · see citing works
Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study
Yen, C., & Chong, M. (2006) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2005.07.006 · Cited by 61 · see citing works
Risk factors for symptom exacerbation among treated patients with substance use disorders
Moos, R. H., Nichol, A. C., & Moos, B. S. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00063.x · Cited by 61 · see citing works
Psychosocial and Behavioral Correlates of Depressed Mood Among Female Methamphetamine Users
Semple, S. J., Zians, J., Strathdee, S. A., & Patterson, T. L. (2007) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2007.10399897 · Cited by 42 · see citing works
Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand
Sutcliffe, C. G., German, D., Sirirojn, B., Latkin, C. A., Aramrattana, A., Sherman, S. G., & Celentano, D. D. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.11.014 · Cited by 38 · see citing works
Methamphetamine and Paranoia: The Methamphetamine Experience Questionnaire
Leamon, M. H., Flower, K., Salo, R. E., NORDAHL, T. E., Kranzler, H. R., & Galloway, G. P. (2010) · American Journal on Addictions · doi:10.1111/j.1521-0391.2009.00014.x · Cited by 37 · see citing works
Self-citationLeamon, M. H., Gibson, D. R., Canning, R. D., et al. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.11.1461 · Cited by 19 · see citing works
Self-citationUnited States. Department of Health and Human Services., & United States. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. (1998) · PsycEXTRA Dataset · doi:10.1037/e481622006-001 · Cited by 19 · see citing works
Comorbid Psychiatric Disorders and Cocaine Abuse
Schottenfeld, R. S., Carroll, K. M., & Rounsaville, B. J. (1993) · PsycEXTRA Dataset · doi:10.1037/e495932006-004 · Cited by 11 · see citing works
Co-Occurring Addiction and Psychiatric Disorders
Greenfield, S. F., & Crisafulli, M. A. (2012) · Oxford University Press eBooks · doi:10.1093/med:psych/9780199738168.003.0007 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A Review
Paulus, M. P., & Stewart, J. L. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.0246 · Cited by 310 · see citing works
Stewart, J. L., May, A. C., Poppa, T., Davenport, P. W., Tapert, S. F., & Paulus, M. P. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.06.003 · Cited by 86 · see citing works
Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study
Hellem, T. L., Sung, Y.-H., Shi, X.-F., Pett, M. A., Latendresse, G., Morgan, J., Huber, R. S., Kuykendall, D., Lundberg, K. J., & Renshaw, P. F. (2015) · Journal of Dual Diagnosis · doi:10.1080/15504263.2015.1100471 · Cited by 49 · see citing works
Shoptaw, S., Li, M. J., Javanbakht, M., Ragsdale, A., Goodman-Meza, D., & Gorbach, P. M. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109320 · Cited by 37 · see citing works
Nardi, W. R., Kelly, P., Roy, A., Becker, S., Brewer, J., & Sun, S. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209442 · Cited by 11 · see citing works
- Authors
- Salo, R., Flower, K., Kielstein, A., Leamon, M. H., Nordahl, T. E., & Galloway, G. P.
- Affiliations
- University of California, Davis (US)
- California Pacific Medical Center (US)
- Corresponding author
- Galloway, Gantt P.
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 186
- Issue
- 2-3
- Pages
- 356-361
- ISSN
- 0165-1781 (ISSN-L)
- PMC
- PMC3058719
- OpenAlex
- W2022547601
- Cited by
- 151
- References
- 35
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 13 · 2023: 10 · 2022: 15 · 2021: 7 · 2020: 10 · 2019: 11 · 2018: 8 · 2017: 11 · 2016: 7 · 2015: 11 · 2014: 8 · 2013: 15 · 2012: 4
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychiatry Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute for Health and Care Research
- National Institutes of Health (5r01da010739-03)
- National Institute on Drug Abuse (DA16329, DA 10641, R21DA014359, R21DA016329, DA14359, R01DA010641, DA10739, K01DA016293)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- methamphetamine dependence, psychiatric comorbidity, drug-induced psychosis, delusional disorder, hallucinations, mood disorders, anxiety disorders, gender differences, lifetime prevalence, DSM-IV diagnosis
- MeSH terms
- Adolescent, Adult, Aged, Mental Disorders, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Severity of Illness Index, Comorbidity, Amphetamine-Related Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
